IL6 inhibition in critically ill COVID-19 patients is associated with increased secondary infections

Lucas M. Kimmig, David Wu, Matthew Gold, Natasha N Pettit, David Pitrak, Jeffery Mueller, Aliya N. Husain, Ece A. Mutlu, Gökhan M. Mutlu
doi: https://doi.org/10.1101/2020.05.15.20103531

Data Availability

Data are available upon responsible request by contacting the corresponding author.

Back to top
Posted May 20, 2020.
Download PDF
Data/Code
Email
IL6 inhibition in critically ill COVID-19 patients is associated with increased secondary infections
Lucas M. Kimmig, David Wu, Matthew Gold, Natasha N Pettit, David Pitrak, Jeffery Mueller, Aliya N. Husain, Ece A. Mutlu, Gökhan M. Mutlu
medRxiv 2020.05.15.20103531; doi: https://doi.org/10.1101/2020.05.15.20103531
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area